Guidance on ICMJE Data Sharing Statements for Investigator-Initiated Research

Effective July 1, 2018 manuscripts submitted to ICMJE journal members must contain a data sharing statement. In connection with this requirement, a related field exists within ClinicalTrials.gov records (i.e., “IPD Sharing Statement”) wherein the applicable sharing plan should be indicated.

The data sharing statement needs to indicate:

  • Whether individual deidentified data will be shared;
  • What data will be shared;
  • Availability of related documents (e.g., study protocol, statistical analysis plan);
  • When the data will be available and for how long;
  • Criteria for obtaining the data.

UNC recommends the following data sharing statement:

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

When data sharing is permitted, a Data Use Agreement (DUA) specifying the uses of such data to be shared must be in place before any data is shared. The Principal Investigator should submit a request to the Office of Industry Contracting for processing. For further information on DUAs, please refer to the Data Use Agreement Guidance.

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


© 2008-2020 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact